Insider Transactions in Q4 2025 at Oric Pharmaceuticals, Inc. (ORIC)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2025
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
37,461
-6.59%
|
$449,532
$12.32 P/Share
|
|
Oct 06
2025
|
Dominic Piscitelli Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,000
-18.54%
|
$154,000
$14.52 P/Share
|
|
Oct 06
2025
|
Dominic Piscitelli Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+15.64%
|
$44,000
$4.36 P/Share
|
|
Oct 03
2025
|
Richard A. Heyman |
BUY
Exercise of conversion of derivative security
|
Direct |
32,800
+22.39%
|
$65,600
$2.68 P/Share
|
|
Oct 01
2025
|
Jacob Chacko PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
53,001
-8.52%
|
$636,012
$12.05 P/Share
|